Global Blood Therapeutics, Inc is a startup based in the United States, most recent round Pre-ipo.
Global Blood Therapeutics, Inc is a company headquartered in the United States. Its most recent tracked round is Pre-ipo.
Global Blood Therapeutics, Inc is a biopharmaceutical company focused on discovering, developing, and delivering therapies for sickle cell disease and other serious blood disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.